Skip to main content
SpringerLink
Log in
Book cover

Pediatric Cancer, Volume 4 pp 217–225Cite as

Ewing’s Sarcoma Family of Tumors: Targeting Molecular Pathways and the Race for a Cure

  • Chapter
  • First Online:

  • 1680 Accesses

Part of the book series: Pediatric Cancer ((PECA,volume 4))

Abstract

Ewing’s sarcoma family of tumors (ESFT) is a malignant tumor of bone and soft tissue in children and adolescents that is characterized by molecular alterations that most commonly involve the EWS gene on chromosome 22. It is an aggressive tumor, with metastases present at diagnosis in 20–25% of cases. Modern treatment regimens for localized disease have resulted in significant improvement in survival. However, the pre­sence of metastasis is associated with morta­lity in 70–80% of patients. New insights into the pathogenesis and prolife­rative mechanisms of human cancers have led to the identification of a number of proteins acting as messenger molecules and modulators of tumor growth. Targeting these molecules in ESFT has the potential effect of controlling tumor growth. This chapter summarizes the current research on molecular pathogenesis, proliferation pathways and new investigational pharmacologic agents that are under development in the race for the cure of this malignancy.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Ahmed AA, Sherman AK, Pawel BR (2011) Expression of therapeutic targets in Ewing sarcoma family tumors. Hum Pathol 43(7):1077–1083

    Article  PubMed  Google Scholar 

  • Applebaum MA, Worch J, Matthay KK, Goldsby R, Neuhaus J, West DC, DuBois SG (2011) Clinical features and outcomes in patients with extraskeletal Ewing sarcoma. Cancer 117:3027–3032

    Article  PubMed  Google Scholar 

  • Arvand A, Denny CT (2001) Biology of EWS/ETS fusions in Ewing’s family tumors. Oncogene 20:5747–5754

    Article  PubMed  CAS  Google Scholar 

  • Bacci G, Balladelli A, Forni C, Longhi A, Serra M, Fabbri N, Alberghini M, Ferrari S, Benassi MS, Picci P (2007) Ewing’s sarcoma family tumours. Differences in clinicopathological characteristics at presentation between localised and metastatic tumours. J Bone Joint Surg Br 89:1229–1233

    PubMed  CAS  Google Scholar 

  • Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Juergens H (2006) Ewing’s sarcoma family of tumors: current management. Oncologist 11:503–519

    Article  PubMed  CAS  Google Scholar 

  • Bjornsti MA, Houghton PJ (2004) The TOR pathway: a target for cancer therapy. Nat Rev Cancer 4:335–348

    Article  PubMed  CAS  Google Scholar 

  • Brenner JC, Feng FY, Han S, Patel S, Goyal SV, Bou-Maroun LM, Liu M, Lonigro R, Prensner JR, Tomlins SA, Chinnaiyan AM (2012) PARP-1 inhibition as a targeted strategy to treat Ewing’s sarcoma. Cancer Res 72:1608–1613

    Article  PubMed  CAS  Google Scholar 

  • Bozzi F, Tamborini E, Negri T, Pastore E, Ferrari A, Luksch R, Casanova M, Pierotti MA, Bellani FF, Pilotti S (2007) Evidence for activation of KIT, PDGFRa, and PDGFRb receptors in the Ewing sarcoma family of tumors. Cancer 109:1638–1645

    Article  PubMed  CAS  Google Scholar 

  • Dalal S, Berry AM, Cullinane CJ, Mangham DC, Grimer R, Lewis IJ, Johnston C, Laurence V, Burchill SA (2005) Vascular endothelial growth factor: a thera­peutic target for tumors of the Ewing’s sarcoma family. Clin Cancer Res 11:2364–2378

    Article  PubMed  CAS  Google Scholar 

  • De Vito C, Riggi N, Suva ML, Janiszewska M, Horlbeck J, Baumer K, Provero P, Stamenkovic I (2011) Let-7a is a direct EWS-FLI-1 target implicated in Ewing’s sarcoma development. PLoS One 6:e23592

    Article  PubMed  Google Scholar 

  • Erkizan HV, Kong Y, Merchant M, Schlottmann S, Barber-Rotenberg JS, Yuan L, Abaan OD, Chou TH, Dakshanamurthy S, Brown ML, Uren A, Toretsky JA (2009) A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing’s sarcoma. Nat Med 15:750–756

    Article  PubMed  CAS  Google Scholar 

  • Faivre S, Kroemer G, Raymond E (2006) Current deve­lopment of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov 5:671–688

    Article  PubMed  CAS  Google Scholar 

  • Giovannini M, Biegel JA, Serra M, Wang JY, Wei YH, Nycum L, Emanuel BS, Evans GA (1994) EWS-erg and EWS-FLI1 fusion transcripts in Ewing’s sarcoma and primitive neuroectodermal tumor with variant translocations. J Clin Invest 94:489–496

    Article  PubMed  CAS  Google Scholar 

  • Girnita L, Girnita A, Wang M, Meis-Kindblom JM, Kindblom LG, Larsso O (2000) A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing’s sarcoma cells. Oncogene 19:4298–4301

    Article  PubMed  CAS  Google Scholar 

  • Grimberg A, Cohen P (2000) Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183:1–9

    Article  PubMed  CAS  Google Scholar 

  • Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8:128–135

    Article  PubMed  CAS  Google Scholar 

  • Herrero-Martin D, Fourtouna A, Niedan S, Riedmann LT, Schwentner R, Arvee DN (2011) Factors affecting EWS-FLI1 activity in Ewing’s sarcoma. Sarcoma 2011:352580

    Article  PubMed  Google Scholar 

  • Ho AL, Schwartz GK (2011) Targeting of insulin-like growth factor type 1 receptor in Ewing sarcoma: unfulfilled promise or a promising beginning? J Clin Oncol 29:4581–4583

    Article  PubMed  CAS  Google Scholar 

  • Jedlicka P (2010) Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions. Int J Clin Exp Pathol 3:338–347

    PubMed  CAS  Google Scholar 

  • Ladenstein R, Potschger U, Le Deley MC, Whelan J, Paulussen M, Oberlin O, Van den Berg H, Dirksen U, Hjorth L, Michon J, Lewis I, Craft A, Jürgens H (2010) Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol 28:3284–3291

    Article  PubMed  CAS  Google Scholar 

  • Lewis TB, Coffin CM, Bernard PS (2007) Differentiating Ewing’s sarcoma from other round blue cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues. Mod Pathol 20:397–404

    Article  PubMed  CAS  Google Scholar 

  • Lin PP, Wang Y, Lozano G (2011) Mesenchymal stem cells and the origin of Ewing’s sarcoma. Sarcoma 2011:2011

    Article  Google Scholar 

  • Mateo-Lozano S, Tirado OM, Notario V (2003) Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhi­bits Ewing’s sarcoma cell proliferation. Oncogene 22:9282–9287

    Article  PubMed  CAS  Google Scholar 

  • McAllister NR, Lessnick SL (2005) The potential for molecular therapeutic targets in Ewing’s sarcoma. Curr Treat Options Oncol 6:461–471

    Article  PubMed  Google Scholar 

  • Miyagawa Y, Okita H, Nakaijima H, Horiuchi Y, Sato B, Taguchi T, Toyoda M, Katagiri YU, Fujimoto J, Hata J, Umezawa A, Kiyokawa N (2008) Inducible expression of chimeric EWS/ETS proteins confers Ewing’s family tumor-like phenotypes to human mesenchymal progenitor cells. Mol Cell Biol 28:2125–2137

    Article  PubMed  CAS  Google Scholar 

  • Nagano A, Ohno T, Shimizu K, Hara A, Yamamoto T, Kawai G, Saitou M, Takiqami I, Matsuhashi A, Yamada K, Takei Y (2010) EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A. Int J Cancer 126:2790–2798

    PubMed  CAS  Google Scholar 

  • Paulussen M, Fröhlich B, Jürgens H (2001) Ewing tumour incidence, prognosis and treatment options. Paediatr Drugs 3:899–913

    Article  PubMed  CAS  Google Scholar 

  • Pinto A, Dickman P, Parham D (2011) Pathobiologic markers of the Ewing sarcoma family of tumors: state of the art and prediction of behaviour. Sarcoma 2011:856190

    Article  PubMed  Google Scholar 

  • Riggi N, Cironi L, Provero P, Suva ML, Kaloulis K, Garcia-Echeverria C, Hoffmann F, Trumpp A, Stamenkovic I (2005) Development of Ewing’s sarcoma from primary bone marrow–derived mesenchymal progenitor cells. Cancer Res 65:11459–11468

    Article  PubMed  CAS  Google Scholar 

  • Riggi N, Suva ML, Suva D, Cironi L, Provero P, Tercier S, Joseph JM, Stehle JC, Baumer K, Kindler V, Stamenkovic I (2008) EWS-FLI-1 expression triggers a Ewing’s sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res 68:2176–2185

    Article  PubMed  CAS  Google Scholar 

  • Rocchi A, Manara MC, Sciandra M, Zambelli D, Filippo Nardi F, Nicoletti G, Garofalo C, Meschini S, Astolfi A (2010) CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis. J Clin Invest 120:668–680

    Article  PubMed  CAS  Google Scholar 

  • Scotlandi K, Benini S, Sarti M, Serra M, Loffini PL, Maurici D, Picci N, Manara MC, BaIdini N (1996) Insulin-like growth factor I receptor-mediated circuit in Ewing’s sarcoma/peripheral neuroecto­dermal tumor: a possible therapeutic target. Cancer Res 56:4570–4574

    PubMed  CAS  Google Scholar 

  • Scotlandi K, Manara MC, Nicoletti G, Lollini PL, Lukas S, Benini S, Croci S, Perdichizzi S, Zambelli D, Serra M, García-Echeverría C, Hofmann F, Picci P (2005) Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. Cancer Res 65:3868–3876

    Article  PubMed  CAS  Google Scholar 

  • Stewart KS, Kleinerman ES (2011) Tumor vessel development and expansion in Ewing’s sarcoma: a review of the vasculogenesis process and clinical trials with vascular targeting agents. Sarcoma 2011:165837

    Article  PubMed  Google Scholar 

  • Subbiah V, Anderson P (2011) Targeted therapy of Ewing’s sarcoma. Sarcoma 2011:686985

    Article  PubMed  Google Scholar 

  • Toomey EC, Schiffman JD, Lessnick SL (2010) Recent advances in the molecular pathogenesis of Ewing’s sarcoma. Oncogene 29:4504–4516

    Article  PubMed  CAS  Google Scholar 

  • Toretsky JA, Kalebic T, Blakesley V, LeRoith D, Helman LJ (1997) The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts. J Biol Chem 272:30822–30827

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children’s Mercy Hospitals and Clinics, 2401 Gillham Road, Kansas City, MO, 64108, USA

    Atif A. Ahmed, Glenson Samuel & Joy M. Fulbright

Authors
  1. Atif A. Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Glenson Samuel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joy M. Fulbright
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Atif A. Ahmed .

Editor information

Editors and Affiliations

  1. , Kean University, Room 213, Library building, Morris Avenue 1000, Union, 07083, New Jersey, USA

    M.A. Hayat

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Ahmed, A.A., Samuel, G., Fulbright, J.M. (2013). Ewing’s Sarcoma Family of Tumors: Targeting Molecular Pathways and the Race for a Cure. In: Hayat, M. (eds) Pediatric Cancer, Volume 4. Pediatric Cancer, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6591-7_21

Download citation

Publish with us

Policies and ethics

Search

Navigation